Home / business / COVID-19 vaccine developer CureVac shares more than triple after U.S. debut

COVID-19 vaccine developer CureVac shares more than triple after U.S. debut

-
Shares of German biotechnology firm CureVac BV soared as much as 222% after their Nasdaq debut on Friday, in the first stock market opening of a company developing a potential vaccine to combat the novel coronavirus.

from Top Business News- News18.com
Read The Rest:timesnownews...
COVID-19 vaccine developer CureVac shares more than triple after U.S. debut COVID-19 vaccine developer CureVac shares more than triple after U.S. debut Reviewed by Team Exprssnews on August 14, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.